Abnormalities of testicular descent

被引:91
作者
Hutson, JM
Hasthorpe, S
机构
[1] Royal Childrens Hosp, Dept Gen Surg, Parkville, Vic 3052, Australia
[2] Murdoch Childrens Res Inst, Douglas Stephens Lab, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
关键词
testicular descent; cryptorchidism; treatment; prognosis; germ cell; human;
D O I
10.1007/s00441-005-1126-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Testicular descent occurs in two stages. The transabdominal phase (8-15 weeks) is controlled by enlargement of the caudal genito-inguinal ligament (gubernaculum) and regression of the cranial ligament. Insulin-like 3 from the Leydig cell appears to be the prime stimulator of gubernacular growth, augmented by Mullerian inhibiting substance/anti-Mullerian hormone. Testosterone causes regression of the cranial ligament. The inguinoscrotal phase (25-35 weeks) requires the migration of the gubernaculum from the groin to the scrotum; this migration is guided by the genito-femoral nerve releasing calcitonin gene-related peptide under the influence of androgen. The neonatal gonocyte transforms into a type A spermatogonium at 3-12 months of age, a step that is now known to be crucial for subsequent fertility, as the stem cells for spermatogenesis are created in this structure. This step is blocked in undescended testis and, hence, orchidopexy is currently recommended at 6-12 months of age. Congenital cryptorchidism is caused by the failure of gubernacular migration to the scrotum (1%-2%) but we now recognise that another 1%-2% of boys have acquired cryptorchidism, secondary to the failure of spermatic cord elongation with growth of the boy. These latter cases come to operation at 5-10 years of age. Surgery remains the mainstay of treatment, as hormonal therapy has not been proven to be effective, presumably because testicular descent is a complex anatomical mechanism.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 38 条
[21]  
HUTSON JM, 1994, PEDIATR SURG INT, V9, P544
[22]   Anatomical and functional aspects of testicular descent and cryptorchidism [J].
Hutson, JM ;
Hasthorpe, S ;
Heyns, CF .
ENDOCRINE REVIEWS, 1997, 18 (02) :259-280
[23]  
HUTSON JM, 1987, PEDIATR SURG INT, V2, P191
[24]  
HUTSON JM, 1992, DESCENT TESTIS, P1
[25]  
HUYNH J, 2005, IN PRESS J UROL
[26]   Cryptorchidism: diagnosis, treatment, and long-term prognosis [J].
Kolon, TF ;
Patel, RP ;
Huff, DS .
UROLOGIC CLINICS OF NORTH AMERICA, 2004, 31 (03) :469-+
[27]   The role of insulin 3, testosterone, Mullerian inhibiting substance and relaxin in rat gubernacular growth [J].
Kubota, Y ;
Temelcos, C ;
Bathgate, RAD ;
Smith, KJ ;
Scott, D ;
Zhao, C ;
Hutson, JM .
MOLECULAR HUMAN REPRODUCTION, 2002, 8 (10) :900-905
[28]  
MIEUSSET R, 1993, FERTIL STERIL, V59, P1319
[29]   Cryptorchidism in mice mutant for Insl3 [J].
Nef, S ;
Parada, LF .
NATURE GENETICS, 1999, 22 (03) :295-299
[30]   HORMONAL-THERAPY OF CRYPTORCHIDISM - A RANDOMIZED, DOUBLE-BLIND-STUDY COMPARING HUMAN CHORIONIC-GONADOTROPIN AND GONADOTROPIN-RELEASING-HORMONE [J].
RAJFER, J ;
HANDELSMAN, DJ ;
SWERDLOFF, RS ;
HURWITZ, R ;
KAPLAN, H ;
VANDERGAST, T ;
EHRLICH, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (08) :466-470